VERU INC. Other Nonoperating Income (Expense)
VERU INC. (VERU) reported Other Nonoperating Income (Expense) of $179.20 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Other Income
us-gaap:OtherNonoperatingIncomeExpense · last filed 2026-08-10
- VERU INC. other nonoperating income (expense) for the quarter ending 2026-06-30 was $179.20K, a 19.78% decline year-over-year.
- VERU INC. other nonoperating income (expense) for the quarter ending 2026-03-31 was $195.00K, a 27.73% decline year-over-year.
- VERU INC. other nonoperating income (expense) for the quarter ending 2025-12-31 was $211.51K, a 29.66% increase year-over-year.
- VERU INC. other nonoperating income (expense) for the quarter ending 2025-09-30 was $112.04K, a 60.00% decline year-over-year.
- VERU INC. other nonoperating income (expense) for fiscal 2025 was $768.38K, a 29.19% decline from fiscal 2024.
- VERU INC. other nonoperating income (expense) for fiscal 2024 was $1.09M, a 89.13% increase from fiscal 2023.
- VERU INC. other nonoperating income (expense) for fiscal 2023 was $573.77K, a 15.74% increase from fiscal 2022.
- VERU INC. other nonoperating income (expense) for fiscal 2022 was $495.74K.
| Period end | Other Nonoperating Income (Expense) 3 month | Other Nonoperating Income (Expense) 3 month as first filed | Other Nonoperating Income (Expense) 6 month | Other Nonoperating Income (Expense) 6 month as first filed | Other Nonoperating Income (Expense) 9 month | Other Nonoperating Income (Expense) 9 month as first filed | Other Nonoperating Income (Expense) 12 month | Other Nonoperating Income (Expense) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $179.20K 10-Q · filed 2026-08-10 | $374.20K derived: sum of 2 quarters · filed 2026-08-10 | $585.72K 10-Q · filed 2026-08-10 | $697.76K derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2026-03-31 | $195.00K 10-Q · filed 2026-05-13 | $406.52K 10-Q · filed 2026-05-13 | $518.56K derived: sum of 3 quarters · filed 2026-05-13 | $741.93K derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-12-31 | $211.51K 10-Q · filed 2026-02-11 | $323.56K derived: sum of 2 quarters · filed 2026-02-11 | $546.93K derived: sum of 3 quarters · filed 2026-08-10 | $816.77K derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-09-30 | $112.04K derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-17 | $335.42K derived: sum of 2 quarters · filed 2026-08-10 | $605.26K derived: sum of 3 quarters · filed 2026-08-10 | $768.38K 10-K · filed 2025-12-17 | ||||
| 2025-06-30 | $223.38K 10-Q · filed 2026-08-10 | $493.21K derived: sum of 2 quarters · filed 2026-08-10 | $656.34K 10-Q · filed 2026-08-10 | $936.43K derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-03-31 | $269.84K 10-Q · filed 2026-05-13 | $432.96K 10-Q · filed 2026-05-13 | $713.05K derived: sum of 3 quarters · filed 2026-05-13 | $1.04M derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | $163.12K 10-Q · filed 2026-02-11 | $443.21K derived: sum of 2 quarters · filed 2026-02-11 | $766.26K derived: sum of 3 quarters · filed 2026-02-11 | $1.14M derived: sum of 4 quarters · filed 2026-02-11 | ||||
| 2024-09-30 | $280.09K derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-17 | $603.13K derived: sum of 2 quarters · filed 2025-12-17 | $980.86K derived: sum of 3 quarters · filed 2025-12-17 | $1.09M 10-K · filed 2025-12-17 | $861.62K 10-K · filed 2024-12-16 | |||
| 2024-06-30 | $323.05K 10-Q · filed 2025-08-12 | $294.12K 10-Q · filed 2024-08-08 | $700.77K derived: sum of 2 quarters · filed 2025-08-12 | $805.11K 10-Q · filed 2025-08-12 | $736.44K 10-Q · filed 2024-08-08 | $969.82K derived: sum of 4 quarters · filed 2025-08-12 | ||
| 2024-03-31 | $377.72K 10-Q · filed 2025-05-08 | $361.23K 10-Q · filed 2024-05-08 | $482.06K 10-Q · filed 2025-05-08 | $442.32K 10-Q · filed 2024-05-08 | $646.77K derived: sum of 3 quarters · filed 2025-05-08 | $777.91K derived: sum of 4 quarters · filed 2025-05-08 | ||
| 2023-12-31 | $104.34K 10-Q · filed 2025-02-13 | $81.09K 10-Q · filed 2024-04-01 | $269.05K derived: sum of 2 quarters · filed 2025-02-13 | $400.19K derived: sum of 3 quarters · filed 2025-02-13 | $457.18K derived: sum of 4 quarters · filed 2025-02-13 | |||
| 2023-09-30 | $164.71K derived: 10-K 12 month − 10-Q 9 month · filed 2024-12-16 | $295.85K derived: sum of 2 quarters · filed 2024-12-16 | $352.84K derived: sum of 3 quarters · filed 2024-12-16 | $573.77K 10-K · filed 2024-12-16 | ||||
| 2023-06-30 | $131.13K 10-Q · filed 2024-08-08 | $372.33K 10-Q · filed 2023-08-10 | $188.13K derived: sum of 2 quarters · filed 2024-08-08 | $409.06K 10-Q · filed 2024-08-08 | $650.25K 10-Q · filed 2023-08-10 | $768.90K derived: sum of 4 quarters · filed 2024-08-08 | ||
| 2023-03-31 | $56.99K 10-Q · filed 2024-05-08 | $277.93K 10-Q · filed 2024-05-08 | $637.76K derived: sum of 3 quarters · filed 2024-05-08 | $707.66K derived: sum of 4 quarters · filed 2024-05-08 | ||||
| 2022-12-31 | $220.93K 10-Q · filed 2024-04-01 | $580.77K derived: sum of 2 quarters · filed 2024-04-01 | $650.66K derived: sum of 3 quarters · filed 2024-04-01 | $652.05K derived: sum of 4 quarters · filed 2024-04-01 | ||||
| 2022-09-30 | $359.84K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2024-04-01 | $429.73K derived: sum of 2 quarters · filed 2024-04-01 | $431.12K derived: sum of 3 quarters · filed 2024-04-01 | $495.74K 10-K/A · filed 2024-04-01 | ||||
| 2022-06-30 | $69.89K 10-Q/A · filed 2023-11-15 | $71.28K derived: sum of 2 quarters · filed 2023-11-15 | $135.90K 10-Q/A · filed 2023-11-15 | $154.37K derived: sum of 4 quarters · filed 2023-11-15 | ||||
| 2022-03-31 | $1.39K 10-Q · filed 2023-05-11 | $66.00K 10-Q · filed 2023-05-11 | $84.48K derived: sum of 3 quarters · filed 2023-05-11 | $49.94K derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | $64.62K 10-Q · filed 2023-02-09 | $83.09K derived: sum of 2 quarters · filed 2023-02-09 | $48.55K derived: sum of 3 quarters · filed 2023-02-09 | $220.00 derived: sum of 4 quarters · filed 2023-02-09 | ||||
| 2021-09-30 | $18.47K derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-05 | -$16.07K derived: sum of 2 quarters · filed 2022-12-05 | -$64.40K derived: sum of 3 quarters · filed 2022-12-05 | -$152.37K 10-K · filed 2022-12-05 | ||||
| 2021-06-30 | -$34.54K 10-Q · filed 2022-08-11 | -$82.87K derived: sum of 2 quarters · filed 2022-08-11 | -$170.84K 10-Q · filed 2022-08-11 | -$234.33K derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | -$48.33K 10-Q · filed 2022-05-12 | -$136.30K 10-Q · filed 2022-05-12 | -$199.79K derived: sum of 3 quarters · filed 2022-05-12 | -$253.13K derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | -$87.97K 10-Q · filed 2022-02-09 | -$151.46K derived: sum of 2 quarters · filed 2022-02-09 | -$204.80K derived: sum of 3 quarters · filed 2022-02-09 | -$152.81K derived: sum of 4 quarters · filed 2022-02-09 | ||||
| 2020-09-30 | -$63.49K derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-02 | -$116.83K derived: sum of 2 quarters · filed 2021-12-02 | -$64.83K derived: sum of 3 quarters · filed 2021-12-02 | -$126.86K 10-K · filed 2021-12-02 | ||||
| 2020-06-30 | -$53.33K 10-Q · filed 2021-08-12 | -$1.34K derived: sum of 2 quarters · filed 2021-08-12 | -$63.37K 10-Q · filed 2021-08-12 | -$56.31K derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | $51.99K 10-Q · filed 2021-05-12 | -$10.04K 10-Q · filed 2021-05-12 | -$2.97K derived: sum of 3 quarters · filed 2021-05-12 | -$1.23K derived: sum of 4 quarters · filed 2021-05-12 | ||||
| 2019-12-31 | -$62.03K 10-Q · filed 2021-02-10 | -$54.96K derived: sum of 2 quarters · filed 2021-02-10 | -$53.22K derived: sum of 3 quarters · filed 2021-02-10 | -$51.23K derived: sum of 4 quarters · filed 2021-02-10 | ||||
| 2019-09-30 | $7.06K derived: 10-K 12 month − 10-Q 9 month · filed 2020-12-10 | $8.81K derived: sum of 2 quarters · filed 2020-12-10 | $10.80K derived: sum of 3 quarters · filed 2020-12-10 | $19.65K 10-K · filed 2020-12-10 | $93.29K 10-K · filed 2019-12-12 | |||
| 2019-06-30 | $1.74K 10-Q · filed 2020-08-13 | $18.34K 10-Q · filed 2019-08-08 | $3.74K derived: sum of 2 quarters · filed 2020-08-13 | $12.59K 10-Q · filed 2020-08-13 | $70.38K 10-Q · filed 2019-08-08 | $30.20K derived: sum of 4 quarters · filed 2020-08-13 | ||
| 2019-03-31 | $1.99K 10-Q · filed 2020-05-13 | $25.64K 10-Q · filed 2019-05-15 | $10.84K 10-Q · filed 2020-05-13 | $52.03K 10-Q · filed 2019-05-15 | $28.45K derived: sum of 3 quarters · filed 2020-05-13 | $28.52K derived: sum of 4 quarters · filed 2020-05-13 | ||
| 2018-12-31 | $26.39K 10-Q · filed 2019-02-13 | $26.46K derived: sum of 2 quarters · filed 2019-12-12 | $26.52K derived: sum of 3 quarters · filed 2019-12-12 | $24.11K derived: sum of 4 quarters · filed 2019-12-12 | ||||
| 2018-09-30 | $65.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-12-12 | $129.00 derived: sum of 2 quarters · filed 2019-12-12 | -$2.28K derived: sum of 3 quarters · filed 2019-12-12 | -$15.45K 10-K · filed 2019-12-12 | ||||
| 2018-06-30 | $64.00 10-Q · filed 2019-08-08 | -$2.35K derived: sum of 2 quarters · filed 2019-08-08 | -$15.52K 10-Q · filed 2019-08-08 | -$26.43K derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2018-03-31 | -$2.41K 10-Q · filed 2019-05-15 | -$2.41K 10-Q · filed 2018-05-11 | -$15.58K 10-Q · filed 2019-05-15 | -$26.49K derived: sum of 3 quarters · filed 2019-05-15 | -$39.82K derived: sum of 4 quarters · filed 2019-05-15 | |||
| 2017-12-31 | -$13.17K 10-Q · filed 2019-02-13 | -$24.08K derived: sum of 2 quarters · filed 2019-02-13 | -$37.41K derived: sum of 3 quarters · filed 2019-02-13 | -$50.09K derived: sum of 4 quarters · filed 2019-02-13 | ||||
| 2017-09-30 | -$10.91K derived: 10-K 12 month − 10-Q 9 month · filed 2018-01-02 | -$24.24K derived: sum of 2 quarters · filed 2018-08-14 | -$36.92K derived: sum of 3 quarters · filed 2018-08-14 | -$46.54K 10-K · filed 2018-01-02 | ||||
| 2017-06-30 | -$13.32K 10-Q · filed 2018-08-14 | -$26.01K derived: sum of 2 quarters · filed 2018-08-14 | -$35.63K 10-Q · filed 2018-08-14 | -$38.13K derived: sum of 4 quarters · filed 2018-08-14 | ||||
| 2017-03-31 | -$12.69K 10-Q · filed 2018-05-11 | -$22.31K 10-Q · filed 2018-05-11 | -$24.81K derived: sum of 3 quarters · filed 2018-05-11 | -$32.21K derived: sum of 4 quarters · filed 2018-05-11 | ||||
| 2016-12-31 | -$9.62K 10-Q · filed 2018-02-14 | -$12.13K derived: sum of 2 quarters · filed 2018-02-14 | -$19.52K derived: sum of 3 quarters · filed 2018-02-14 | -$38.88K derived: sum of 4 quarters · filed 2018-02-14 | ||||
| 2016-09-30 | -$2.50K derived: 10-K 12 month − 10-Q 9 month · filed 2018-01-02 | -$9.90K derived: sum of 2 quarters · filed 2018-01-02 | -$29.26K derived: sum of 3 quarters · filed 2018-01-02 | -$57.06K 10-K · filed 2018-01-02 | ||||
| 2016-06-30 | -$7.40K 10-Q · filed 2017-08-09 | -$26.75K derived: sum of 2 quarters · filed 2017-08-09 | -$54.55K 10-Q · filed 2017-08-09 | -$39.27K derived: sum of 4 quarters · filed 2018-01-02 | ||||
| 2016-03-31 | -$19.36K 10-Q · filed 2017-05-10 | -$47.15K 10-Q · filed 2017-05-10 | -$31.87K derived: sum of 3 quarters · filed 2018-01-02 | -$33.81K derived: sum of 4 quarters · filed 2018-01-02 | ||||
| 2015-12-31 | -$27.80K 10-Q · filed 2017-02-09 | -$12.52K derived: sum of 2 quarters · filed 2018-01-02 | -$14.46K derived: sum of 3 quarters · filed 2018-01-02 | -$18.30K derived: sum of 4 quarters · filed 2018-01-02 | ||||
| 2015-09-30 | $15.28K derived: 10-K 12 month − 10-Q 9 month · filed 2018-01-02 | $13.34K derived: sum of 2 quarters · filed 2018-01-02 | $9.50K derived: sum of 3 quarters · filed 2018-01-02 | $10.15K 10-K · filed 2018-01-02 | ||||
| 2015-06-30 | -$1.94K 10-Q · filed 2016-07-28 | -$5.78K derived: sum of 2 quarters · filed 2016-07-28 | -$5.13K 10-Q · filed 2016-07-28 | |||||
| 2015-03-31 | -$3.84K 10-Q · filed 2016-04-28 | -$3.19K 10-Q · filed 2016-04-28 | ||||||
| 2014-12-31 | $652.00 10-Q · filed 2016-02-02 | |||||||
| 2014-09-30 | $117.12K 10-K · filed 2016-12-12 | |||||||
| 2013-09-30 | $245.54K 10-K · filed 2015-12-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |